57517-54-1 Usage
Description
(+)-(14β)-Dihydrovinpocetine is a stereoisomer of (-)-Dihydroapovincaminic Acid Ethyl Ester (D448350), which is a chiral modifier utilized in enantioselective heterogeneous catalytic hydrogenations. It shares a structural resemblance with Vinpocetine (V332500), a well-known vasodilator that specifically targets the cerebral region.
Uses
Used in Pharmaceutical Industry:
(+)-(14β)-Dihydrovinpocetine is used as a chiral modifier for enantioselective heterogeneous catalytic hydrogenations, which is crucial in the synthesis of various pharmaceutical compounds. Its ability to influence the stereochemistry of reactions allows for the production of specific enantiomers with desired biological activities, enhancing the efficacy and safety of medications.
Used in Cerebral Vasodilation:
(+)-(14β)-Dihydrovinpocetine is used as a vasodilator in the cerebral region, similar to its structurally related compound, Vinpocetine. This application is beneficial for promoting improved blood flow to the brain, which can have positive effects on cognitive function, memory, and overall brain health.
Check Digit Verification of cas no
The CAS Registry Mumber 57517-54-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,5,1 and 7 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 57517-54:
(7*5)+(6*7)+(5*5)+(4*1)+(3*7)+(2*5)+(1*4)=141
141 % 10 = 1
So 57517-54-1 is a valid CAS Registry Number.
57517-54-1Relevant articles and documents
(-)-Dihydro-apovincaminic acid ethyl ester, preparation and use as a chiral modifier in enantioselective heterogeneous catalytic hydrogenations
Tungler,Mathe,Tarnai,Fodor,Toth,Kajtar,Kolossvary,Herenyi,Sheldon
, p. 2395 - 2402 (2007/10/03)
The preparation, characterisation and use of (-)-dihydro-apovincaminic acid ethyl ester as a chiral modifier in heterogeneous catalytic asymmetric hydrogenations is reported. The epimeric compositions were determined using NMR and HPLC methods and circular dichroism spectroscopy was used to detect the interaction between the chiral modifier and the substrate.
